Susquehanna International Group
NVLN

Susquehanna International Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Susquehanna International Group’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,454
Closed -$10K – 11435
2019
Q2 		$10K Buy
+12,454
New +$13.9K ﹤0.01% 10081
2019
Q1 		– Sell
-48,476
Closed -$42K – 11292
2018
Q4 		$42K Buy
+48,476
New +$54.8K ﹤0.01% 8539
2018
Q3 		– Hold
0
– – – 11634
2018
Q2 		– Hold
0
– – – 11626
2018
Q1 		– Sell
-12,007
Closed -$50.9K – 11313
2017
Q4 		$37K Buy
+12,007
New +$57.7K ﹤0.01% 8989
2017
Q2 		– Hold
0
– – – 10832
2017
Q1 		– Hold
0
– – – 10902
2016
Q4 		– Hold
0
– – – 10842

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $38.5M AUM 24.72% 1-Year Est. Return
HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return